Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan-Feb;53(1):1-6.
doi: 10.1590/0100-3984.2019.0034.

Use of PET/CT to aid clinical decision-making in cases of solitary pulmonary nodule: a probabilistic approach

Affiliations

Use of PET/CT to aid clinical decision-making in cases of solitary pulmonary nodule: a probabilistic approach

Felipe Alves Mourato et al. Radiol Bras. 2020 Jan-Feb.

Abstract

Objective: To determine the frequency with which 18F-FDG-PET/CT findings change the probability of malignancy classification of solitary pulmonary nodules.

Materials and methods: This was a retrospective analysis of all 18F-FDG-PET/CT examinations performed for the investigation of a solitary pulmonary nodule between May 2016 and May 2017. We reviewed medical records and PET/CT images to collect the data necessary to calculate the pre-test probability of malignancy using the Swensen model and the Herder model. The probability of malignancy was classified as low if < 5%, intermediate if 5-65%, and high if > 65%. Cases classified as intermediate in the Swensen model were reclassified by the Herder model.

Results: We reviewed the records for 33 patients, of whom 17 (51.5%) were male. The mean age was 68.63 ± 12.20 years. According to the Swensen model, the probability of malignancy was intermediate in 23 cases (69.7%). Among those, the application of the Herder model resulted in the probability of malignancy being reclassified as low in 6 (26.1%) and as high in 8 (34.8%).

Conclusion: 18F-FDG-PET/CT was able to modify the probability of malignancy classification of a solitary pulmonary nodule in more than 50% of the cases evaluated.

Keywords: Clinical decision-making; Decision support techniques; Medical oncology; Positron emission tomography; Pulmonary medicine; Solitary pulmonary nodule.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Variation in the probability of malignancy classification per patient according to each model.
Figure 2
Figure 2
Examples of the use of 18F-FDG-PET/CT in SPNs. A: A nodule for which the probability of malignancy was 33.2% on the basis of clinical and CT findings, decreasing to 10% when the absence of 18F-FDG uptake was taken into account (a follow-up CT scan at two years out showed that the nodule had disappeared). B: A nodule for which the probability of malignancy was 6.2% on the basis of clinical and CT findings, increasing to 75.8% when the moderate 18F-FDG uptake was taken into account (a subsequent biopsy revealed an adenocarcinoma).

References

    1. Harzheim D, Eberhardt R, Hoffmann H, et al. The solitary pulmonary nodule. Respiration. 2015;90:160–172. - PubMed
    1. Holin SM, Dwork RE, Glaser S, et al. Solitary pulmonary nodules found in a community-wide chest roentgenographic survey; a five-year follow-up study. Am Rev Tuberc. 1959;79:427–439. - PubMed
    1. Henschke CI, Naidich DP, Yankelevitz DF, et al. Early lung cancer action project: initial findings on repeat screenings. Cancer. 2001;92:153–159. - PubMed
    1. Mott TF. Lung cancer: screening and evaluation of patients with solitary pulmonary nodules. FP Essent. 2018;464:17–22. - PubMed
    1. Ito M, Miyata Y, Okada M. Management pathways for solitary pulmonary nodules. J Thorac Dis. 2018;10(Suppl 7):S860–S866. - PMC - PubMed

LinkOut - more resources